phloretin has been researched along with imatinib mesylate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Babendreier, E; Chauhan, D; Chu, SC; Gramlich, JL; Griffin, JD; Kim, JH; Podar, K; Pride, YB; Salgia, R; Sattler, M | 1 |
| Caliceti, C; Fiorentini, D; Hakim, G; Hrelia, S; Prata, C; Vieceli Dalla Sega, F; Zambonin, L | 1 |
2 other study(ies) available for phloretin and imatinib mesylate
| Article | Year |
|---|---|
Activation of the PI3K/mTOR pathway by BCR-ABL contributes to increased production of reactive oxygen species.
Topics: Benzamides; Cell Line; Cell Line, Tumor; Cell Transformation, Neoplastic; Deoxyglucose; Enzyme Activation; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Jurkat Cells; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Monosaccharide Transport Proteins; Phloretin; Phosphatidylinositol 3-Kinases; Piperazines; Protein Kinases; Pyrimidines; Reactive Oxygen Species; Signal Transduction; TOR Serine-Threonine Kinases; Tyrosine; Up-Regulation | 2005 |
Effect of plasma membrane cholesterol depletion on glucose transport regulation in leukemia cells.
Topics: Benzamides; beta-Cyclodextrins; Cell Line, Tumor; Cell Membrane; Cell Proliferation; Cell Survival; Cholesterol; Cytoplasmic Vesicles; Endocytosis; Extracellular Signal-Regulated MAP Kinases; Glucose; Glucose Transporter Type 1; Humans; Imatinib Mesylate; Leukemia; Nystatin; Phloretin; Phospholipase C gamma; Phosphorylation; Piperazines; Protein Kinase Inhibitors; Protein Processing, Post-Translational; Protein Transport; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-akt; Pyrimidines; Stem Cell Factor | 2012 |